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Introduction
Alopecia areata (AA) is a chronic dermatological 
condition that is characterized by sudden and 
unpredictable hair loss, ranging from minor 
patches to loss of all scalp and body hair. About 
2 percent of the population is affected by this 
condition. No clear cause or effective treatment 
is currently available. Although AA is medically 
a benign condition, due to accompanying appear-
ance changes, persons often experience a low-
ered self-esteem, self-confidence, and heightened 
self-consciousness (Hunt and McHale, 2005), 
which negatively impacts their social lives 
(Dubois et al., 2010). Even though most people 
with AA hide their condition (e.g. wear a wig), 
they often do experience disease-related distress 
(Wiggins et al., 2014). Specifically, higher 
anxiety and depression levels (Sellami et al., 
2014) and more social life disturbances (Dubois 
et al., 2010) have been found compared to per-
sons without hair loss. As such, particularly the 
psychosocial quality-of-life (QoL) aspects, gen-
erally consisting of emotional well-being (e.g. 
negative mood) and social functioning (e.g. 
social support), seem adversely affected in AA 
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(e.g. Tucker, 2009). Thus far, there is limited 
insight into the variables associated with QoL in 
this group (Cartwright et al., 2009). Based on the 
Common Sense Model (CSM) of Self-Regulation 
of health and illness (Leventhal et al., 2001), 
this study aims to examine the role of illness per-
ceptions and coping in relation to QoL, in order 
to provide further direction for interventions to 
improve QoL in persons with AA.
According to the CSM, health outcomes of 
patients with chronic conditions are influenced 
by their cognitive and emotional illness percep-
tions. These enable patients to make sense of 
their symptoms and may impact on health out-
comes directly or through their influence on 
coping actions (Leventhal et al., 2001). Illness 
perceptions reveal persons’ implicit illness rep-
resentations, derived from multiple sources such 
as medical advice, bodily sensations, and others’ 
reactions (Henderson et al., 2009). Distinguished 
are beliefs about identity (the description or 
view of symptoms involved with having the 
condition), timeline (how long the person 
believes the condition will last), consequences 
(the expected effects and outcome of the condi-
tion), control (the amount of control the patient 
feels he/she has over the illness and the extent to 
which he/she considers the medical treatment to 
help), coherence (the extent to which the person 
has a clear understanding of the condition), and 
cause (personal ideas about the cause of the con-
dition). Additionally, two emotional compo-
nents include the degree of concern (level of 
concern experienced regarding the condition) 
and emotional representation (personal percep-
tion of the influence the condition has on experi-
encing emotions such as fear and anger) 
(Broadbent et al., 2006).
Illness perceptions have shown to play a pre-
dictive role in health outcomes in many illnesses 
(e.g. Hagger and Orbell, 2003). Only limited 
research has been conducted in dermatological 
conditions that show similarity in the visibility 
of the signs and symptoms, chronicity, and 
unpredictable nature, being contact dermatitis, 
atopic dermatitis, and psoriasis. Studies in these 
populations have shown similar associations 
as in other illnesses, with stronger identity 
perceptions, perceiving a longer timeline, and a 
stronger perception of the disease as having neg-
ative consequences being mostly associated 
with more psychological distress and stronger 
controllability/curability beliefs with better psy-
chological well-being (Benyamini et al., 2012; 
Hagger and Orbell, 2003; Scharloo et al., 2000; 
Wittkowski et al., 2007). In the single study on 
illness perceptions in alopecia, beliefs about 
more serious consequences, strong emotional 
representations regarding the perceived influ-
ence on well-being, and stronger identity per-
ceptions were cross-sectionally related to poorer 
QoL (Cartwright et al., 2009). Causal attribu-
tions were not significantly related to QoL in 
this study, but strong beliefs of blaming oneself 
for developing a condition were related to psy-
chological distress in other dermatological sam-
ples (Fortune et al., 2000; Wittkowski et al., 
2007).
In the CSM, illness representations are 
assumed to guide individual’s coping actions and 
impact on QoL (partly) through that route 
(Leventhal et al., 2001). With regard to coping, 
three main dimensions are distinguished: avoid-
ant (e.g. self-blame), problem-focused (e.g. plan-
ning), and active emotional coping (e.g. humor) 
(Lazarus and Folkman, 1984). Across illnesses, 
more avoidant coping is generally considered to 
be maladaptive and problem-focused coping 
adaptive in terms of psychological health (e.g. 
Hesselink et al., 2004; Lazarus and Folkman, 
1984). Yet, illness characteristics and percep-
tions may determine how a coping strategy is 
related to QoL. In uncontrollable conditions, 
such as AA, both avoidant and problem-focused 
coping were associated with impaired QoL 
(Cartwright et al., 2009), while in conditions 
with more (perceived) control options, problem-
focused coping was related to good QoL (e.g. 
Lazarus and Folkman, 1984). The adaptiveness 
of emotion-focused coping strategies is unclear; 
a lack of controllability could increase a focus on 
the health threat, subsequently creating anxiety 
(Bolger, 1990), which could be dealt with by 
emotion-focused strategies. An association 
between emotion-focused coping and better psy-
chological functioning was found in psoriasis 
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(Hill and Kennedy, 2002), but not in alopecia 
(Cartwright et al., 2009).
In various populations, illness perceptions 
were found to be associated with coping. For 
example, more personal control perceptions 
have been related to adaptive coping and per-
ceiving more consequences to maladaptive cop-
ing (e.g. Hallas et al., 2011). Also, support has 
been found for the postulated mediating role of 
coping between illness perceptions and health 
outcomes. For instance, the association between 
more negative illness perceptions and poorer 
QoL was mediated by emotional coping in peo-
ple with hepatocellular carcinoma (Fan et al., 
2013). Also, avoidant coping partly mediated 
the relation between a stronger illness identity 
and psychiatric morbidity in women with rheu-
matoid arthritis (Carlisle et al., 2005). However, 
some studies failed to support the mediating 
role of coping (e.g. Graham et al., 2014).
Since research on the role of illness percep-
tions and the mediating role of coping is limited 
in dermatological conditions, and non-existent 
in AA, this study aims to examine the associa-
tions between illness perceptions and QoL and 
to explore the mediating role of coping in this 
association in persons with AA. It was hypoth-
esized that more negative illness perceptions 
(perceiving AA with a greater identity, longer 
duration, more consequences, more negative 
emotional representations, and more internal 
causal attributions) will be related to lower QoL 
and more positive illness perceptions (perceiv-
ing AA as a controllable condition and under-
standing the condition) with better QoL. Given 
the uncontrollability of AA, avoidant and prob-
lem-focused coping were hypothesized to be 
related to worse QoL and emotion-focused cop-
ing to better QoL. Finally, coping was hypoth-
esized to (partially) mediate the association 
between illness perceptions and QoL.
Method
Participants and procedure
An (English or Dutch) online survey on QoL 
and its potential determinants was completed 
by 243 persons with AA. Inclusion criteria were 
being ≥16 years and reporting to be diagnosed 
with AA by a dermatologist or general practi-
tioner. Participants were recruited through a 
link on social media pages/websites of (inter)
national alopecia support groups and gave 
informed consent. The study was approved by 
the Ethics Committee Psychology of the Faculty 
of Social and Behavioural Sciences of Leiden 
University.
Of 351 people starting the survey, 243 (69%) 
completed the questionnaires included in this 
article. Dropouts and completers did not differ 
significantly with regard to gender, QoL, AA 
duration, and AA clinical severity. The final 
sample includes participants from 25 countries, 
with the most prevalent countries of residence 
being the United States (N = 60), United 
Kingdom (N = 60), The Netherlands (N = 38), 
Canada (N = 28), and Australia (N = 15).
Measures
QoL. The Dermatology Life Quality Index 
(DLQI) is a QoL measure for persons with a 
dermatological condition, consisting of 10 
items on daily activities, symptoms and feel-
ings, leisure, work/school, treatment, and per-
sonal relationships (Finlay and Khan, 1994). 
An example item is Over the last week, how 
much has your skin (replace by “alopecia” for 
this study) affected any social or leisure activi-
ties? In this study, the word “skin” was replaced 
by “alopecia.” The items are scored using a 
4-point Likert scale (from 0—not at all/not rel-
evant to 3—very much). The effect of AA on 
QoL was categorized into five categories, from 
no effect (0–1) to an extremely large effect (21–
30; Hongbo et al., 2005). Internal consistency 
was high in this sample (Cronbach’s alpha = .87).
Illness perceptions. The eight-item Brief Illness 
Perception Questionnaire (Brief-IPQ), measures 
eight cognitive and emotional representation 
dimensions regarding one’s condition: conse-
quences, timeline, personal control, treatment 
control, identity, coherence (understanding), 
emotional representation, and concern. Items are 
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scored on a Likert scale from 0 to 10. Conform-
ing to earlier studies, “your illness” was replaced 
with the disease/condition (“alopecia areata”). 
Higher scores on the dimensions personal con-
trol, treatment control, and coherence indicate 
more positive illness perceptions; for the other 
dimensions, higher scores indicate more nega-
tive illness perceptions (Broadbent et al., 2006).
To study the illness dimension Cause, an 
item from the original IPQ with 16 possible 
causes of the condition from the patient’s per-
spective was included (Moss-Morris et al., 
2002). The participants indicated the extent to 
which they (dis)agree that these are causes for 
their AA, using a 5-point Likert scale ranging 
from 1 (strongly disagree) to 5 (strongly agree). 
Principal component analysis (PCA) with 
Varimax rotation on the 16 causes led to removal 
of four items that loaded ≤.45, leaving three fac-
tors with eigenvalues above 1.0, explaining 
61.7 percent of the variance: (1) internal causes 
(eight causes, e.g. family problems or worries, 
own behavior; α = .89), (2) external causes/
immunity (three causes, germ/virus, pollution/
environment, and altered immunity; α = .74), 
and (3) chance/bad luck (1 item).
Coping strategies. The Brief-COPE covers 14 
coping dimensions, each assessed by two items 
(Cartwright et al., 2009; Carver, 1997) and was 
introduced asking participants how they coped 
with stress since their AA diagnosis. Items were 
scored on a 4-point Likert scale (from 1—“I have 
not been doing this at all” to 4—“I have been 
doing this a lot”). Based on previous research 
(Cartwright et al., 2009), three main coping strat-
egies were distinguished: problem-focused 
(including active coping, planning, religion, and 
instrumental support), active emotional coping 
(including venting, positive reframing, emotional 
support, humor, and acceptance), and avoidant 
coping (including self-distraction, denial, behav-
ioral engagement, self-blame, and substance use). 
Cronbach’s alphas varied between .80 and .82.
Demographic/clinical data. Questions were 
included about (1) demographics: gender, age, 
living situation, work situation, and country of 
residence and (2) duration and perceived clini-
cal characteristics of AA: first onset, percentage 
of hair loss, periods of remission, stability, tex-
ture–color change, and perceived severity. The 
extent of AA was measured according to Olsen 
et al.’s (1999) investigational guidelines. As 
loss of eyebrows and/or eyelashes combined 
with hair loss on the scalp can be seen as pro-
gression of the condition, this was added to the 
general category of scalp. The severity of the 
condition was rated as extensive (>50% hair 
loss), moderate (20%–50% hair loss), or mild 
(<20% hair loss).
Statistical analysis
Scale scores were normally distributed with the 
exception of timeline (kurtosis = 5.16). To exam-
ine the relationship between illness perceptions 
and QoL, and the mediating role of coping in the 
illness perceptions–QoL association, a series of 
regression analyses were conducted. Mediation 
was tested by the following steps: (1) the illness 
perceptions (predictor) are significantly related to 
QoL (outcome), (2) the illness perceptions are sig-
nificantly related to coping (mediator), (3) coping 
is significantly related to QoL, controlling for ill-
ness perceptions, and (4) the relation between ill-
ness perceptions and QoL is significantly reduced 
after the inclusion of coping as a predictor. In all 
regressions, demographic/clinical characteristics 
that were significantly related to both predictor(s) 
and outcome were controlled. The data were ana-
lyzed using SPSS (version 22.0; IBM Corp., 
2013). The significance of the indirect effect of ill-
ness perceptions on QoL through coping was 
determined by the Sobel test and by a bootstrap-
ping method, using the program MEDIATE for 
SPSS (Preacher and Hayes, 2004).
Results
Demographic and clinical 
characteristics in relation to QoL
Participants were mostly female (89%) and living 
together with a partner, family, or friend(s) (83%); 
had a mean age of 37.9 years (standard deviation 
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(SD) = 13.0 years); and were employed (69%). 
Average disease duration was 15.3 years 
(SD = 12.9 years), with 68 and 53 percent report-
ing >50 percent hair loss of the scalp and eye-
brows/eyelashes, respectively. No significant QoL 
differences were found between men and women 
(p = .33), living alone versus together (p = .34), and 
different amounts of hair loss (p = .10). More QoL 
impairment was found in participants not working 
(t(241) = −3.59, p < .001), being younger (r = −.19, 
p = .002), and with a shorter AA duration (r = −.14, 
p =. 03).
Using cutoff scores for the DLQI indicated 
that 84 percent of the sample had at least some 
QoL impairment, with 29 percent (n = 71) 
reporting a small effect, 24 percent (n = 58) a 
moderate effect, 26 percent (n = 62) a very large 
effect, and 5 percent (n = 13) an extremely large 
effect. The remaining 15 percent (n = 37) 
reported no effect of alopecia on QoL.
Associations between illness 
perceptions and QoL
Descriptive characteristics and zero-order cor-
relations of QoL, illness perceptions, and cop-
ing are presented in Table 1. The high mean and 
limited variance in the illness perceptions 
dimension timeline indicates that most persons 
considered their AA to be chronic. More QoL 
impairment was related to beliefs about AA 
having more consequences, a stronger illness 
identity, more concern about AA, higher scores 
on emotional representations (all p val-
ues < .001), experiencing less personal control 
(p = .003), and less coherence (p = .002). Illness 
perceptions regarding timeline and treatment 
control were unrelated to QoL. More QoL 
impairment was associated with attributing AA 
to external and internal causes (p values < .001), 
but not to chance/bad luck (p = .73).
The relative contribution of illness percep-
tions on QoL is reported in Table 2. After con-
trolling for demographic/clinical characteristics 
that were significantly related to both predictor(s) 
and outcome (i.e. age, work situation, and AA 
duration), the illness perceptions accounted for a 
significant 49.7 percent additional explained 
variance in QoL. More QoL impairment was 
predicted by higher perceived AA consequences 
(p < .001), more emotional representations 
(p = .004), a stronger illness identity (p = .04), 
and attributing AA to a lesser extent to chance or 
bad luck (p = .04). Because the correlation 
between chance/bad luck attribution and QoL 
was non-significant, this suppressor effect was 
further examined: at higher levels of concern, 
bad luck/chance attribution was associated with 
lower QoL impairment, whereas at low concern, 
no significant association was found.
The mediating role of coping in the 
illness perceptions—QoL association
Univariately (see Table 1), more avoidant cop-
ing (p < .001) and less active emotional coping 
(p = .007) were associated with more QoL 
impairment, whereas problem-focused coping 
was unrelated. All illness perceptions, except 
timeline, were significantly related to at least 
one coping strategy.
To examine the direct and mediating effect of 
coping, first, the relative contribution of illness 
perceptions on coping, after controlling for age, 
work situation, and AA duration, was assessed 
(see Table 2). Together, the illness perceptions 
significantly explained 45.3 percent of the vari-
ance in avoidant coping, 18 percent in problem-
focused coping, and 15 percent in active 
emotional coping. More emotional AA represen-
tations (p = .006), more perceived consequences 
(p = .006), a stronger illness identity (p = .002), 
and perceiving internal causes (p < .001) were 
predictive of more avoidant coping. Lower con-
cern (p = .01) and stronger attribution of AA to 
chance/bad luck (p = .004) were predictive of 
more active emotional coping. Finally, experi-
encing more AA consequences (p < .001), lower 
concern (p = .02), higher perceived treatment 
control (p = .02), and stronger attribution of AA 
to internal causes (p = .01) were predictive of 
more problem-focused coping.
Regressing QoL on both illness perceptions 
and coping, controlling for demographic and 
clinical AA variables (Table 2), showed that 
only avoidant coping significantly predicted 
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Table 2. Results regression analyses on the relationship between illness perceptions, coping strategies, 
and quality of life, examining the mediating role of coping strategies. Controlled for age, work status, and 
alopecia areata (AA) duration (results not reported).
Coping strategies regressed on illness perceptions (IP)
 Coping strategies
 Avoidant 
coping
Active emotional 
coping
Problem-focused coping 
 β β β
IP consequences .22** .09 .38***
IP timeline −.06 .01 −.09
IP personal control −.07 .06 .04
IP treatment control .03 −.06 .18*
IP identity .18** −.04 .04
IP concern −.07 −.31* −.27*
IP coherence −.03 .07 .09
IP emotional representation .27** −.13 −.13
IP cause internal .25*** .11 .20*
IP cause external .05 .13 .09
IP chance/bad luck .10 .20** .08
 ∆R2 = .45
∆F = 17.78
p < .001
∆R2 = .15
∆F = 3.35
p < .001
∆R2 = .18
∆F = 4.25
p < .001
Quality of life regressed on illness perceptions (IP) and coping strategies
 Quality of life (DLQI)
 β β β β
IP consequences .29*** .23** .30*** .28***
IP timeline −.04 −.02 −.04 −.04
IP personal control −.07 −.05 −.06 −.07
IP treatment control −.04 −.06 −.05 −.05
IP identity .11* .06 .11* .11
IP concern .12 .14 .10 .12
IP coherence −.04 −.03 −.03 −.04
IP emotional representation .26** .19* .25** .26**
IP cause internal .06 −.01 .07 .06
IP cause external .08 .07 .09 .08
IP chance/bad luck −.10* −.12** −.08 −.10*
Avoidant coping .27***  
Active emotional coping −.07  
Problem-focused coping .02
 ∆R2 = .50
∆F = 23.27
p < .001
∆R2 = .04
∆F = 19.57
p < .001
∆R2 = .004
∆F = 2.20
p = .14
∆R2 < .001
∆F = 0.25
p = .61
DLQI: Dermatology Life Quality Index.
*p < .05, **p < .01, ***p < .001.
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QoL beyond the illness perceptions (p < .001), 
accounting for an additional 3.5 percent of the 
variance in QoL. The illness perceptions conse-
quences, emotional representations, and the 
causal chance/bad luck attribution remained 
significant QoL predictors, indicating no full 
mediation by avoidant coping. Identity was no 
longer significant, suggesting a full mediating 
effect. The Sobel test confirmed avoidant cop-
ing as a significant mediator in the association 
of consequences (z = 3.63, p < .001), emotional 
representations (z = 3.71, p = .001), chance/bad 
luck attribution (z = 3.05, p = .001), and identity 
(z = 2.77, p < .001) with QoL, which were all 
confirmed using a bootstrapping method (con-
sequences: bootstrapped point estimate = 0.0126 
(standard error (SE) = 0.0054), 95% confidence 
interval (CI) lower–upper = 0.0042–0.0263; 
emotional representations: estimate = 0.0137 
(SE = 0.0064), 95% CI lower–upper = 0.0042–
0.0300; bad luck/chance attribution: esti-
mate = 0.0120 (SE = 0.0067), 95% CI 
lower–upper = 0.0014–0.0287; identity: esti-
mate = 0.0094 (SE = 0.0038), 95% CI lower–
upper = 0.0035–0.0188). This analysis also 
indicated a significant indirect effect of internal 
causal attribution (estimate = 0.0441 (SE = 
0.0158), 95% CI lower–upper = 0.0193–0.0830) 
on QoL through avoidant coping.
Discussion
This study, including a large sample of people 
with AA, confirmed the previously found QoL 
impairment in persons with alopecia (e.g. 
Tucker, 2009). In the current sample, 84 percent 
experienced at least some QoL impairment and 
31 percent experienced a very or extremely 
large QoL impairment. These percentages are 
comparable to, or even higher than, QoL impair-
ments of persons with visible vitiligo and pso-
riasis (Chung et al., 2014; Ingordo et al., 2013). 
The main findings of this study are that both 
illness perceptions and coping strategies are 
associated with QoL outcomes among AA per-
sons and that avoidant coping (partially) medi-
ates the association between illness perceptions 
and QoL.
With the exception of timeline and treat-
ment control, all illness perceptions were uni-
variately related to QoL. Controlling for 
relevant demographic and clinical characteris-
tics, especially the illness perceptions, conse-
quences, identity, and emotional 
representations were found to be important for 
QoL in AA. These results are in line with the 
previous alopecia study in which the same ill-
ness perceptions were related to QoL 
(Cartwright et al., 2009). Also in samples of 
people with other chronic conditions, identity 
and consequences have been associated with 
psychological distress (e.g. Benyamini et al., 
2012; Hagger and Orbell, 2003; Scharloo 
et al., 2000; Wittkowski et al., 2007). The ill-
ness cognition of emotional representations 
has been examined less often than the other ill-
ness perceptions, simply due to the fact that 
this illness perception was more recently 
added to the questionnaire (Moss-Morris et al., 
2002). However, the results for emotional rep-
resentation found are in line with previous 
studies showing that a chronic condition 
affects the experience of negative emotions 
(e.g. anger, anxiety, and depression) and thus 
contributes to impaired psychosocial QoL 
(Cartwright et al., 2009).
Regarding causal attributions, attributing 
the condition to chance or bad luck was found 
to be predictive of less QoL impairment, espe-
cially among persons with a high score on con-
cern. An explanation could be that ascribing a 
condition to chance or bad luck which not only 
eliminates possible feelings of regret, frustra-
tion, or sorrow of past actions that might have 
caused the condition but also eliminates think-
ing of having to make lifestyle adjustments. 
Thus, when attributing AA to chance or bad 
luck, worrying about past actions that might 
have caused the condition or overthinking pre-
sent and future actions that might control the 
condition, seem irrelevant. The finding that 
chance attributions, which were reported by 
45 percent of the sample, were related to QoL 
could indicate an AA-specific relevant causal 
attribution, since this has not been found in 
other dermatological conditions, such as 
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eczema (e.g. Wittkowski et al., 2007). However, 
more research is needed to elucidate this issue.
To summarize the findings on illness percep-
tions, the dimensions consequences, identity, 
emotional representations, and causal attribu-
tion to chance/bad luck have been identified as 
relevant predictors of QoL in AA and conse-
quently seem to be an important intervention 
target to improve QoL in people with this 
condition.
Of the coping strategies examined, only 
avoidant coping was predictive of QoL beyond 
the effect of illness perceptions. The finding 
that avoidant coping was related to worse QoL 
is consistent with previous studies in (chronic) 
disease populations (e.g. Hesselink et al., 2004). 
It might be explained by the finding of thought 
suppression increasing frequency of these 
thoughts and associated moods (Wenzlaff et al., 
1991). Active emotional coping was signifi-
cantly correlated with QoL, in line with the 
notion that it would be a beneficial coping strat-
egy given the uncontrollability of the condition 
of AA. However, its lack of predictive value 
beyond the effect of illness perceptions sug-
gests that this coping strategy need not be the 
primary aim of interventions to improve QoL in 
AA. Also, problem-focused coping was not 
related to QoL in our sample, in contrast to the 
single previous study on QoL in alopecia that 
found that more problem-focused coping was 
related to poorer QoL (Cartwright et al., 2009). 
However, it is in line with research indicating 
that in conditions that cannot be brought under 
control by treatment or personal behavioral 
changes, problem-focused coping may not be 
effective (Affleck et al., 1987; Hagger and 
Orbell, 2003). Thus, mainly avoidant coping 
seems to be of relevance for impaired QoL in 
people with AA, warranting further investiga-
tion into this association.
According to the Common Sense Model, ill-
ness perceptions may determine how people 
cope with a condition, which consequently can 
improve or worsen psychological health out-
comes (Leventhal et al., 2001). With regard to 
avoidance coping, this hypothesized mediation 
effect was found. Labeling AA as a condition 
with a greater identity, perceiving more conse-
quences, reporting more emotional representa-
tions, and attributing AA less to chance/bad 
luck predicted poorer QoL, partially or totally 
(for identity) through increased use of adverse 
avoidant coping strategies. Furthermore, even 
though attributing AA to internal causes was 
not directly related to QoL, it seemed to exert 
an indirect effect through avoidant coping. This 
provides theoretical insight into the specific 
pathway through which illness perceptions 
impact on QoL in people with AA and provides 
indications on where to intervene on to improve 
QoL of people with AA.
Although longitudinal studies are needed to 
confirm causality, current results suggest some 
practical implications for QoL interventions in 
AA populations. First, education about the role 
of negative illness perceptions (e.g. stronger 
identity and more emotional representations) 
and avoidant coping strategies (e.g. denial, self-
distraction, and self-blame) for QoL could be 
provided to persons with AA and relevant 
health-care professionals. Second, challenging 
negative illness perceptions and changing them 
into more positive ones could be effective in 
reducing QoL impairment. Previous studies on 
cardiac and asthma patients have shown that 
modification of illness perceptions is feasible 
and leads to enhanced outcomes (e.g. Petrie 
et al., 2002, 2012). Also, the causal attribution of 
the condition deserves attention, as the findings 
suggest that attribution to internal causes relates 
to more maladaptive avoidance coping, whereas 
attribution to chance may exert a direct positive 
influence on QoL. Third, reducing the use of 
avoidant coping strategies (e.g. self-blame and 
denial) would be a final aspect to address. On 
one hand, changing illness perceptions could 
already result in a decrease in avoidant coping. 
On the other hand, direct interventions to reduce 
avoidant coping and stimulate more positive 
coping strategies such as positive reframing and 
acceptance may also help reduce QoL impair-
ment. The feasibility and value of such an 
approach has been illustrated, for instance, in a 
recent study examining the effects of accept-
ance-oriented cognitive–behavioral therapy in 
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highly distressed patients with rheumatic dis-
eases (Vriezekolk et al., 2013).
This study has some strengths and limita-
tions. First, based on the Common Sense Model 
and using valid measures, this is the first study 
to examine the mediating role of coping 
between illness perceptions and QoL in AA per-
sons. Second, the recruitment of AA partici-
pants was performed through online support 
groups, which has resulted in an international 
and large sample, including people with AA 
from 25 countries. Additionally, variability of 
QoL scores, AA duration, age, and AA severity 
was large enough to be confident about having 
reached an adequate sample to examine the 
relations between illness perceptions, coping, 
and QoL. However, the recruitment method 
could have led to an overrepresentation of peo-
ple who are in need for and seek support. Those 
who are coping well might be less likely to be 
members of support groups. Yet, this recruit-
ment process could have biased the sample in 
another direction as well, since positive changes 
in well-being in support groups have been 
found (Kalabokes, 2011). Additionally, given 
the online data collection, the diagnosis of AA 
could not be verified. Further studies could 
recruit persons through medical centers and/or 
general practitioners to reduce these potential 
biases. Another limitation concerns the cross-
sectional design of the study. As a consequence, 
causality between illness perceptions, coping, 
and QoL cannot be determined. Reverse or 
reciprocal relationships might also be plausible. 
A longitudinal study could provide insight into 
the causality and explore whether changes over 
time in illness perceptions and coping are 
related to changes in QoL.
Conclusion
This study aimed to improve understanding of 
the relationships between illness perceptions, 
coping strategies, and QoL in persons with AA, 
using Leventhal’s Common Sense Model. 
Particularly, the illness perceptions conse-
quences, identity, emotional representations, 
and avoidant coping, were found to be related to 
QoL. The hypothesized mediating role of cop-
ing in the association between illness percep-
tions and QoL was partially confirmed, with 
perceiving AA with a greater identity (perceiv-
ing more symptoms) being fully mediated by 
avoidant coping in explaining poorer QoL and 
perceiving more consequences, reporting 
greater emotional representations, and attribut-
ing AA to chance/bad luck being partially medi-
ated by avoidant coping. These findings provide 
indications for the development of interven-
tions focusing on changing illness perceptions 
and on reducing avoidant coping in order to 
improve QoL in persons with this chronic 
condition.
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